{"id":12073,"date":"2024-05-07T09:19:09","date_gmt":"2024-05-07T07:19:09","guid":{"rendered":"https:\/\/www.nanomesurefrance.fr\/?p=12073"},"modified":"2024-05-13T13:30:03","modified_gmt":"2024-05-13T11:30:03","slug":"rapport-annuel-du-nci-ncl","status":"publish","type":"post","link":"https:\/\/www.nanomesurefrance.fr\/en\/rapport-annuel-du-nci-ncl\/","title":{"rendered":"NCI-NCL Annual Report"},"content":{"rendered":"<p><img decoding=\"async\" class=\"size-medium wp-image-12074 aligncenter\" src=\"https:\/\/www.nanomesurefrance.fr\/wp-content\/uploads\/2024\/05\/2023-NCL-Annual-Report-cover_0-570x570.jpg\" alt=\"\" width=\"570\" height=\"570\" srcset=\"https:\/\/www.nanomesurefrance.fr\/wp-content\/uploads\/2024\/05\/2023-NCL-Annual-Report-cover_0-570x570.jpg 570w, https:\/\/www.nanomesurefrance.fr\/wp-content\/uploads\/2024\/05\/2023-NCL-Annual-Report-cover_0-80x80.jpg 80w, https:\/\/www.nanomesurefrance.fr\/wp-content\/uploads\/2024\/05\/2023-NCL-Annual-Report-cover_0-13x12.jpg 13w\" sizes=\"(max-width: 570px) 100vw, 570px\" \/><\/p>\n<p>Visit <strong>Nanotechnology Characterization Laboratory<\/strong> (<a href=\"https:\/\/www.cancer.gov\/nano\/research\/ncl\/about\" target=\"_blank\" rel=\"noopener\">NCL<\/a>) was founded by the National Cancer Institute (NCI) in 2004, <strong>in collaboration with the FDA and <a href=\"https:\/\/www.nist.gov\/nanomaterials\" target=\"_blank\" rel=\"noopener\">NIST<\/a><\/strong>as part of a public-private partnership aimed at advancing the science required for the future.<span style=\"color: #3366ff;\"><span style=\"color: #000000;\">e<strong> to accelerate the development of promising nanotechnology-based therapies and diagnostics<\/strong><\/span><\/span><span style=\"color: #000000;\">. <\/span><\/p>\n<p>NCL, part of the <a href=\"https:\/\/frederick.cancer.gov\/\" target=\"_blank\" rel=\"noopener\">Frederick National Laboratory for Cancer Research<\/a> (FNLCR), tested <strong>more than 500 unique nanomaterials<\/strong> submitted by over 125 researchers from all over the world.<\/p>\n<p>NCL has just published its <strong>annual report 2023<\/strong>which highlights advances in research and trends in applications, including :<\/p>\n<ul>\n<li>The NCL test cascade (submission and application trends)<\/li>\n<li>Protocols and new technologies<\/li>\n<li>Nanotechnology formulation<\/li>\n<li>Publication of validated and recognized harmonized characterization methods<\/li>\n<\/ul>\n<p>NCL launches a <strong>call for applications<\/strong> for several cutting-edge technologies:<\/p>\n<ul>\n<li>Lipid nanoparticles (LNP)<\/li>\n<li>Nucleic acid-based therapeutic nanotechnologies<\/li>\n<li>Imaging agents<\/li>\n<li>Immunotherapies<\/li>\n<\/ul>\n<p>International requests for NCL services represent 19% of the total number of requests received, and the dossiers submitted have an acceptance rate of 48%.<\/p>\n<p><strong>If you're developing any of these technologies, NCL is interested in hearing from you!<\/strong><\/p>\n<p>Visit our website <a href=\"https:\/\/www.cancer.gov\/nano\/research\/ncl\/about-0\" target=\"_blank\" rel=\"noopener\">https:\/\/www.cancer.gov\/nano\/research\/ncl\/about-0<\/a>\u00a0 for more information<\/p>\n<script type=\"text\/javascript\"> toolTips('.classtoolTips1','Il esiste plusieurs d\u00e9finition d\\'un <span class='tooltipsall tooltipsincontent classtoolTips1'>nanomat\u00e9riau<\/span>. <br\/>Selon l\\'<span class='tooltipsall tooltipsincontent classtoolTips13'>ISO<\/span> 8004-1: mat\u00e9riau ayant une dimension ext\u00e9rieure \u00e0 l\u2019\u00e9chelle nanom\u00e9trique  ou ayant une structure interne ou une structure de surface \u00e0 l\u2019\u00e9chelle nanom\u00e9trique.<br\/><br\/>Selon la recommandation de d\u00e9finition europ\u00e9enne C(2022) 3689:<br\/>On entend par \u00abnanomat\u00e9riau\u00bb un mat\u00e9riau naturel, form\u00e9 accidentellement ou manufactur\u00e9, constitu\u00e9 de particules solides qui sont pr\u00e9sentes soit individuellement soit en tant que particules constitutives identifiables dans des agr\u00e9gats ou des agglom\u00e9rats, 50 % au moins de ces particules, dans la r\u00e9partition num\u00e9rique par taille, r\u00e9pondant au moins \u00e0 l\u2019une des conditions suivantes:<br\/>(a) une ou plusieurs dimensions externes de la particule se situent dans la fourchette de 1 nm \u00e0 100 nm;<br\/>(b) la particule pr\u00e9sente une forme allong\u00e9e, telle que celle d\u2019un b\u00e2tonnet, d\u2019une fibre ou d\u2019un tube, deux dimensions externes \u00e9tant inf\u00e9rieures \u00e0 1 nm et l\u2019autre dimension sup\u00e9rieure \u00e0 100 nm;<br\/>(c) la particule pr\u00e9sente une forme de plaque, une dimension externe \u00e9tant inf\u00e9rieure \u00e0 1 nm et les autres dimensions sup\u00e9rieures \u00e0 100 nm.<br\/>Pour d\u00e9terminer la r\u00e9partition num\u00e9rique par taille des particules, il n\u2019est pas n\u00e9cessaire de prendre en consid\u00e9ration les particules ayant au moins deux dimensions externes orthogonales sup\u00e9rieures \u00e0 100 \u03bcm.<br\/>Un mat\u00e9riau pr\u00e9sentant une surface sp\u00e9cifique en volume inf\u00e9rieure \u00e0 6 m2\/cm3 n\u2019est toutefois pas consid\u00e9r\u00e9 comme un <span class='tooltipsall tooltipsincontent classtoolTips1'>nanomat\u00e9riau<\/span>.<br\/> Texte complet: https:\/\/eur-lex.europa.eu\/legal-content\/FR\/TXT\/HTML\/?uri=CELEX%3A32022H0614%2801%29'); <\/script><script type=\"text\/javascript\"> toolTips('.classtoolTips12','Comit\u00e9 Europ\u00e9en de Normalisation https:\/\/www.cencenelec.eu\/about-cen\/'); <\/script>","protected":false},"excerpt":{"rendered":"<p>Le Laboratoire de Caract\u00e9risation des Nanotechnologies (NCL) a \u00e9t\u00e9 fond\u00e9 par le National Cancer Institute (NCI) en 2004, en collaboration avec la FDA et le NIST, dans le cadre d&rsquo;un partenariat public-priv\u00e9 visant \u00e0 faire progresser la science n\u00e9cessaire pour acc\u00e9l\u00e9rer le d\u00e9veloppement de th\u00e9rapies et de diagnostics prometteurs dans le domaine des nanotechnologies. Le NCL, qui fait partie du Frederick National Laboratory for Cancer Research (FNLCR), a test\u00e9 plus de 500 nanomat\u00e9riaux uniques soumis par plus de 125 chercheurs du monde entier. Le NCL vient de publier son rapport annuel 2023, qui met en \u00e9vidence les progr\u00e8s r\u00e9alis\u00e9s dans la recherche et les tendances en mati\u00e8re d&rsquo;applications, notamment : La cascade d&rsquo;essais du NCL (tendances en mati\u00e8re de soumission et d&rsquo;application) Protocoles et nouvelles technologies Formulation de nanotechnologies La publication de m\u00e9thodes de caract\u00e9risation harmonis\u00e9e valid\u00e9es et reconnues Le NCL lance un appel \u00e0 candidatures pour plusieurs technologies de pointe : Nanoparticules lipidiques (LNP) Nanotechnologies th\u00e9rapeutiques \u00e0 base d&rsquo;acides nucl\u00e9iques Agents d&rsquo;imagerie Immunoth\u00e9rapies Les demandes internationales pour b\u00e9n\u00e9ficier des services du NCL repr\u00e9sente 19% du total des sollicitations re\u00e7ues et les dossiers soumis ont un taux d&rsquo;acceptation de 48%. Si vous d\u00e9veloppez l&rsquo;une de ces technologies, le NCL est int\u00e9ress\u00e9 de recevoir une demande de votre part! Visitez le site https:\/\/www.cancer.gov\/nano\/research\/ncl\/about-0\u00a0 pour plus d&rsquo;informations<\/p>","protected":false},"author":1,"featured_media":12074,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84],"tags":[119,113,85],"class_list":["post-12073","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-autres","tag-biomedical","tag-international","tag-nanomedecine","cms-has-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/posts\/12073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/comments?post=12073"}],"version-history":[{"count":0,"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/posts\/12073\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/media\/12074"}],"wp:attachment":[{"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/media?parent=12073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/categories?post=12073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nanomesurefrance.fr\/en\/wp-json\/wp\/v2\/tags?post=12073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}